Latest Breaking News On - World insights - Page 1 : comparemela.com

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic profile based on the relevant PK modeling data Additional.

Caris and COTA Partner to Expand Cancer Care with AI-Powered RWD Platform

Caris Life Sciences Logo What You Should Know:  - Caris Life Sciences (Caris), a leader in AI-powered precision medicine, and COTA, Inc., a real-world data (RWD) and analytics expert, announced a strategic collaboration today. -

This photo shows tents of the

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024